Retraction notices

The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib

Type

Correction

Notice date

2/18/2019 0:00

Journal

British Journal of Haematology

Publisher

Wiley

Notice DOI

10.1111/bjh.15766

Original paper DOI

10.1111/bjh.12206

Reasons

• Duplication of/in Image
• Falsification/Fabrication of Image
• Investigation by Company/Institution
• Investigation by ORI
• Misconduct - Official Investigation(s) and/or Finding(s)
• Misconduct by Author

Matching venue names

Name match only, not an authoritative journal identifier.

• British Journal of Haematology